(S)-1-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-2-phenylbut-3-en-2-amine fumarate
97%
- Product Code: 113630
CAS:
1214741-14-6
| Molecular Weight: | 519.43 g./mol | Molecular Formula: | C₂₄H₂₃F₆NO₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD29059866 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, protected from light, stored in an inert gas |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of neurokinin-1 (NK1) receptor antagonists. These antagonists are crucial in the development of medications aimed at treating conditions such as chemotherapy-induced nausea and vomiting, as well as certain types of depression and anxiety disorders. The specific stereochemistry of the compound ensures high selectivity and efficacy in binding to the NK1 receptor, making it a valuable component in the production of targeted therapeutic agents. Additionally, its structural features contribute to the overall stability and bioavailability of the final drug product, enhancing its effectiveness in clinical applications.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $32.55 |
+
-
|
| 0.250 | 10-20 days | $55.15 |
+
-
|
| 1.000 | 10-20 days | $148.72 |
+
-
|
(S)-1-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-2-phenylbut-3-en-2-amine fumarate
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of neurokinin-1 (NK1) receptor antagonists. These antagonists are crucial in the development of medications aimed at treating conditions such as chemotherapy-induced nausea and vomiting, as well as certain types of depression and anxiety disorders. The specific stereochemistry of the compound ensures high selectivity and efficacy in binding to the NK1 receptor, making it a valuable component in the production of targeted therapeutic agents. Additionally, its structural features contribute to the overall stability and bioavailability of the final drug product, enhancing its effectiveness in clinical applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :